Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
2006; Wiley; Volume: 46; Issue: 1 Linguagem: Inglês
10.1111/j.1365-4632.2006.03079.x
ISSN1365-4632
AutoresJohn E. Wolf, Douglas Shander, Ferdinand Huber, Jeanne Jackson, Chensheng Lin, Barbara Mathes, Kathy Schrode,
Tópico(s)Contact Dermatitis and Allergies
ResumoInternational Journal of DermatologyVolume 46, Issue 1 p. 94-98 Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair John E. Wolf Jr MD, John E. Wolf Jr MD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorDouglas Shander PhD, Douglas Shander PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorFerdinand Huber BS, Ferdinand Huber BS From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorJoseph Jackson PhD, Joseph Jackson PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorChen-Sheng Lin PhD, Chen-Sheng Lin PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorBarbara M. Mathes MD, Barbara M. Mathes MD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorKathy Schrode PhD, Kathy Schrode PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorthe Eflornithine HCl Study Group, the Eflornithine HCl Study Group Eflornithine study group: Wilma F. Bergfeld, MD, Francisco Camacho, MD, Adrian S. Dobs, MD, Frank Dunlap, MD, Maria Hordinsky, MD, Irving H. Katz, MD, Mark Lebwohl, MD, Amy McMichael, MD, Elise A. Olsen, MD, David M. Pariser, MD, Daniel Piacquadio, MD, Vera Price, MD, Geoffrey P. Redmond, MD, David Rodriguez, MD, Marty E. Sawaya, MD PhD, Jonathan S. Weiss, MD, David A. Whiting, MD, David C. Wilson, MD, John E. Wolf, Jr. MDSearch for more papers by this author John E. Wolf Jr MD, John E. Wolf Jr MD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorDouglas Shander PhD, Douglas Shander PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorFerdinand Huber BS, Ferdinand Huber BS From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorJoseph Jackson PhD, Joseph Jackson PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorChen-Sheng Lin PhD, Chen-Sheng Lin PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorBarbara M. Mathes MD, Barbara M. Mathes MD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorKathy Schrode PhD, Kathy Schrode PhD From the Baylor College of Medicine, Houston, TX, Gillette Advanced Technology Center/US, Needham, MA, Bristol-Myers Squibb, Princeton, NJSearch for more papers by this authorthe Eflornithine HCl Study Group, the Eflornithine HCl Study Group Eflornithine study group: Wilma F. Bergfeld, MD, Francisco Camacho, MD, Adrian S. Dobs, MD, Frank Dunlap, MD, Maria Hordinsky, MD, Irving H. Katz, MD, Mark Lebwohl, MD, Amy McMichael, MD, Elise A. Olsen, MD, David M. Pariser, MD, Daniel Piacquadio, MD, Vera Price, MD, Geoffrey P. Redmond, MD, David Rodriguez, MD, Marty E. Sawaya, MD PhD, Jonathan S. Weiss, MD, David A. Whiting, MD, David C. Wilson, MD, John E. Wolf, Jr. MDSearch for more papers by this author First published: 03 January 2007 https://doi.org/10.1111/j.1365-4632.2006.03079.xCitations: 87 Dr John E. Wolf, Jr, MD Baylor College of Medicine Suite 1050 1709 Dryden Houston TX 77030-3411 USA E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume46, Issue1January 2007Pages 94-98 RelatedInformation
Referência(s)